Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
about
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration.Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Structural Basis of Microtubule Stabilization by Discodermolide.Synemin: an evolving role in tumor growth and progressionInhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.
P2860
Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
@en
type
label
Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
@en
prefLabel
Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
@en
P2093
P1476
Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.
@en
P2093
Arun Kanakkanthara
John H Miller
Paul H Teesdale-Spittle
P304
P356
10.2174/187152013804487263
P577
2013-01-01T00:00:00Z